NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/modivcare-inc-lawsuit-submi ...

RADNOR, Pa., Feb. 13, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against ModivCare Inc. ("ModivCare") (NASDAQ: MODV) on behalf of those who purchased or otherwise acquired ModivCare securities between November 3, 2022, and September 15, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is March 31, 2025.CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered ModivCare losse ...

Core Points - The Gross Law Firm has issued a notice to shareholders of ModivCare Inc. regarding a class action lawsuit related to alleged false statements and omissions that negatively impacted the company's financial performance [1][2] - The class period for the lawsuit is from November 3, 2022, to September 15, 2024, during which shareholders are encouraged to register for potential recovery [1][2] - Allegations include that ModivCare's NEMT segment contracts led to a deterioration in free cash flow, negatively affecting adjusted EBITDA and liquidity, while the company's positive statements were misleading [1] Summary by Sections Class Action Details - Shareholders who purchased shares of ModivCare during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1] - The deadline for shareholders to register for the class action is March 31, 2025, and there is no cost to participate [2] Allegations Against ModivCare - The complaint alleges that ModivCare made false statements regarding its business operations and financial health, particularly concerning contract renegotiations and pricing accommodations [1] - The negative impact on free cash flow and adjusted EBITDA is highlighted as a significant concern for the company's financial stability [1] Firm's Commitment - The Gross Law Firm is recognized for its commitment to protecting investors' rights and ensuring companies adhere to responsible business practices [3] - The firm aims to recover losses for investors affected by misleading statements that inflated the company's stock value [3]

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/modivcare-inc-lawsuit-submi ...

BENSALEM, Pa., Feb. 10, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV).IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MODIVCARE, INC. (MODV), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 31, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.Contact the Law Offices of How ...

Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment caused a deterioration in the company's free cash flow [1]. - As a result of these issues, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company was reported to have insufficient liquidity, and the defendants' positive statements regarding the company's business and prospects were deemed materially misleading [1]. Group 2: Class Action Details - The class period for the allegations spans from November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ModivCare To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in ModivCare between November 3, 2022 and May 3, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, Feb. 7, 2025 /PRNewswire/ ...

Core Viewpoint - A class action securities lawsuit has been filed against ModivCare Inc. for alleged securities fraud affecting investors between November 3, 2022, and September 15, 2024 [1][2] Group 1: Lawsuit Details - The lawsuit claims that ModivCare made false statements and concealed information regarding contracts in its Non-Emergency Medical Transportation (NEMT) segment, which led to a deterioration in free cash flow [2] - Allegations include that contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA, resulted in insufficient liquidity, and that positive statements made by the defendants were materially misleading [2] Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [1]. - As a result of these contracts, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company reportedly faced insufficient liquidity, and the defendants' positive statements about the company's business and prospects were misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for shareholders who purchased shares of ModivCare is from November 3, 2022, to September 15, 2024 [1]. - Shareholders are encouraged to register for the class action by March 31, 2025, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case, and they will receive status updates through a portfolio monitoring software [2].

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or the "Company") (NASDAQ: MODV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether ModivCare and certain of its officers ...